CYCLOSERINE, 250mg, caps. blister

STD DORACYCL2C1

Valid Article

Former Code(s): DORACYCL2C- DORAMISC284 DORAZBD0284
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AB01
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

CYCLOSERINE

Therapeutic Action

Antimycobacterial

Indications

Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The 125 mg capsule is intended for paediatric use.

Must be taken with water before or after meals.

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.

The quantity to be ordered is calculated per capsule, not per blister.

Precautions for Use

Avoid in patients with epilepsy, depression, psychosis, severe anxiety, history of neurological or psychiatric disorders, chronic alcohol use.

Avoid alcohol during treatment.

Storage

Below 25ºC - Protect from humidity